Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: a longitudinal study (Q46350540)

21 December 2017

title

Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: a longitudinal study (English)

1 reference

21 December 2017

0 references

2

Stephen D Lawn

1 reference

21 December 2017

Motasim Badri

1

0 references

Robin Wood

series ordinal

3

object named as

Robin Wood

1 reference

PubMed ID

17027731

21 December 2017

language of work or name

English

0 references

publication date

1 October 2006

1 reference

21 December 2017

published in

The Lancet

1 reference

21 December 2017

volume

368

1 reference

21 December 2017

issue

9543

1 reference

21 December 2017

page(s)

1254-1259

1 reference

21 December 2017

Cost-effectiveness of highly active antiretroviral therapy in South Africa

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969117-4

7 January 2021

Prognosis in HIV-1 infection predicted by the quantity of virus in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969117-4

7 January 2021

Quantitative HIV-1 RNA as a marker of clinical stability and survival in a cohort of 302 patients with a mean CD4 cell count of 300 x 10(6)/l

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969117-4

7 January 2021

Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969117-4

7 January 2021

AIDS prognosis based on HIV-1 RNA, CD4+ T-cell count and function: markers with reciprocal predictive value over time after seroconversion.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969117-4

7 January 2021

Influences of age, viral load, and CD4+ count on the rate of progression of HIV-1 infection to AIDS. Transfusion Safety Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969117-4

7 January 2021

Immune markers and viral load after HIV-1 seroconversion as predictors of disease progression in a cohort of haemophilic men.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969117-4

7 January 2021

The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969117-4

7 January 2021

Plasma HIV-1 RNA to guide patient selection for antiretroviral therapy in resource-poor settings: efficiency related to active case finding

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969117-4

7 January 2021

Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969117-4

7 January 2021

Initiating highly active antiretroviral therapy in sub-Saharan Africa: an assessment of the revised World Health Organization scaling-up guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969117-4

7 January 2021

HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969117-4

7 January 2021

Seroconversion rate, mortality, and clinical manifestations associated with the receipt of a human immunodeficiency virus-infected blood transfusion in Kinshasa, Zaire

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969117-4

7 January 2021

Predictors of mortality among HIV-infected women in Kigali, Rwanda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969117-4

7 January 2021

Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969117-4

7 January 2021

The prognostic value of the World Health Organisation staging system for HIV infection and disease in rural Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969117-4

7 January 2021

Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969117-4

7 January 2021

Plasma viral load, CD4 cell percentage, HLA and survival of HIV-1, HIV-2, and dually infected Gambian patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969117-4

7 January 2021

Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969117-4

7 January 2021

Antiretroviral treatment in resource-poor settings: clinical research priorities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969117-4

7 January 2021

Methods for the analysis of informatively censored longitudinal data

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2806%2969117-4

7 January 2021

10.1016/S0140-6736(06)69117-4

Identifiers

DOI

1 reference

21 December 2017

PubMed ID

17027731

1 reference

21 December 2017